H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 11.9% of adults in New York have diagnosed diabetes — about even with the U.S. 12% figure. Census population 8,336,817. New York Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed New York clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a New York storefront.
Collagen Injection Therapy in New York, NY for clinics & physicians. Collagen injection therapy products f… Compliance support & pricing — contact Hawk Medical.
Adult obesity in New York is 25.1% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 11.9% of adults in New York have diagnosed diabetes — about even with the U.S. 12% figure. New York is outside CDC’s core Diabetes Belt list; use the PLACES city rate anyway. Hawk Medical is the distributor for collagen injection therapy, not a walk-in clinic.
National Collagen Injection Therapy notes (how the product actually works)America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For New York we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 11.9% of adults in New York have diagnosed diabetes — about even with the U.S. 12% figure.
We are not going to invent a New York warehouse or a five-star local review. What you get is collagen injection therapy from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JK, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 11.9% of adults — about even with the U.S. 12% figure. Obesity is 25.1%; arthritis is 19.9%. That is place-level BRFSS modeling, not a clinic census and not a New York trial.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including New York.
Yes — receiving, storage, indication, and documentation templates are part of onboarding. SOPs still have to be adopted as the clinic’s own procedures; we do not pretend to be the medical director in New York.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. National Government Services (NGS) LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
Ask for the IFU, the lot-traceability packet, and the National Government Services (NGS) article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a New York fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in New York, NY.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for New York is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for New York — about even with the U.S. 12% figure. Planning input, not an outcomes claim.
New York Part B wound biologics follow this contractor (siblings: CT, MA, ME, NH, RI, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in New York. Useful for joint-program math; still needs a diagnosis and privileging.
No New York storefront. Joe Bradley is an active practice owner. collagen injection therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.